Kwick Forensic Solutions IPO Financials, Risk Factors, Peers & Objects of Issue
An investor-focused breakdown of the Kwick Forensic Solutions IPO offer document: restated financial performance, key ratios, valuation across the price band, competitive strengths, risk factors, listed peers, objects of the issue and the business model, all drawn from the company's RHP disclosures.
Back to the Kwick Forensic Solutions IPO report → (allotment, subscription, GMP)
Kwick Forensic Solutions IPO Financial Performance (Restated)
On a restated consolidated basis, the company revenue increased by 63% and profit after tax (PAT) rose by 58% between the financial year ending with March 31, 2026, a useful one-line read on operating momentum heading into the listing.
Here is how the books have moved over the last three financial years:
31 Mar 2026 to 31 Mar 2024₹ Crore
All figures in ₹ Crore unless stated otherwise. Source: restated financials disclosed in the offer documents.
Profits have scaled from ₹2.83 Cr to ₹13.51 Cr over two years. For investors, the trend matters more than any single year, steady compounding with contained leverage is what institutional bidders typically reward, while a late spike in borrowings deserves scrutiny against the stated objects of the issue.
Kwick Forensic Solutions IPO Key Performance Indicators (KPI)
ROE38.98%
RoCE44.88%
Return on Net Worth32.62%
Debt / Equity0.12
NAV per share24.54
Price to Book5.44
Reading these numbers. RoE and RoCE measure how efficiently the business turns shareholder capital into profit; anything in double digits is respectable, mid-twenties plus is strong. A debt-to-equity ratio well below 1 signals a balance sheet that does not depend on lenders. NAV per share anchors the book value of your bid, while price-to-book tells you how many rupees the issue is charging for each rupee of that book, compare it with listed peers in the same sector before deciding whether the premium is justified.
Kwick Forensic Solutions IPO Valuation, Pre IPO vs Post IPO
The issue price converts into a different earnings multiple once the fresh shares hit the books. Here is the dilution-adjusted picture:
EPS (₹)8.00→ 6.30 post-IPO
P/E (x)11.25→ 14.29 post-IPO
Market Cap at offer₹152Cr→ ₹192.93 Cr post-IPO
Pre-IPO figures are computed on the pre-issue share count; post-IPO figures assume full subscription at the upper band.
Kwick Forensic Solutions IPO Risk Factors (per RHP)
- Revenue heavily concentrated in final quarter Q4 FY2024-25 accounted for 51% of total yearly sales, inflating year-end trade receivables and creating lumpiness in cash flows
- Customer concentration in government entities with non-negotiable long payment terms Client base historically majorly government entities; payment terms non-negotiable, typically 70-90 days with multi-stage inspection delays
- Extended receivable cycles tying up significant capital Debtor days 83 (FY24), 89 (FY25), 74 (FY26); trade receivables grew from Rs. 1,193.58 lakhs to Rs. 2,288.07 lakhs (Mar 2024-26)
- High working capital intensity funded largely by IPO proceeds Projected working capital gap Rs. 4,442 lakhs for FY27; IPO proceeds Rs. 3,142 lakhs (71% of gap) with zero bank funding assumed
- Declining access to bank financing for working capital Bank/borrowing funding fell from Rs. 185.93 lakhs (FY24) to Rs. 57.68 lakhs (FY25) to zero (FY26); projected zero for FY27
- Rapid inventory buildup in specialized forensic equipment Inventories rose from Rs. 328.73 lakhs (Mar 2024) to Rs. 1,043.71 lakhs (Mar 2026); projected Rs. 1,350 lakhs for FY27 (48 inventory days)
- Limited bargaining power over key imported components forcing faster supplier payments Creditor days projected to drop from 44 (FY26) to 30 (FY27) due to suppliers insisting on shorter credit periods for specialized/imported components
- Dependence on government tender-led business with unpredictable payment cycles Tender-based contracts require stocking critical kits/consumables, funding fabrication/integration, and multi-stage payments through government departments
- Increasing cash tied up in government balances and tax assets Other current assets (advance tax, TDS recoverable, govt balances) rose to 7.79% of revenue in FY26 (28 days holding period)
- Working capital projections rely on aggressive management assumptions FY27 assumes debtor days stabilize at 74, creditor days cut to 30, inventory days rise to 48; any deviation could widen funding gap beyond IPO proceeds
It is essential to read the complete risk factors in the offer document before investing; this list summarises the key disclosures only.
Kwick Forensic Solutions IPO Business Model
- Company has been in the same line of business for 3 years with at least 50% of revenue from operations from such continued business activity.
- Registered office of the company is situated in Chennai, Tamil Nadu.
Kwick Forensic Solutions IPO Industry Snapshot
- Company holds MSME registration for Software Development and Assembling (2008) and NSIC Government Purchase Enlistment for CCTV Camera and Networking Products (valid Feb 2026–Feb 2028).
- Quality certifications include ISO 9001:2015, ISO 14001:2015, ISO/IEC 20000-1:2018, ISO/IEC 27001:2022, and CE Low Voltage Directive (2014/35/EU) compliance for forensic hardware.
- EPR Registration under E-Waste (Management) Rules, 2022 (valid Dec 2024–Dec 2029) and DSIR registration for customs duty exemption (valid Feb 2025–Mar 2027).
- Trademarks registered: "SARAL-AL" (Class 9, valid to Feb 2027), "KWICK SOFT" across Classes 9, 42, 45 (valid to May 2029); multiple new applications pending for Kwick Forensic Solutions brand.
- No industry market size, CAGR, demand drivers, or sector-specific government policies disclosed in this excerpt.
Disclaimer: The financial data on this page is auto-extracted from the company's offer document (RHP/DRHP) and is provided for education only. DostIpo is not a SEBI-registered investment adviser; verify all figures against the official prospectus before making any investment decision. Investments in the securities market are subject to market risks.
View the complete Kwick Forensic Solutions IPO report: allotment status, subscription, GMP & review →
Last updated: 02 Sep 2026, 22:24 IST